• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ArgL 可能靶向 COVID-19 相关的炎症小体诱导的 ARDS 和细胞因子风暴。

Arglabin could target inflammasome-induced ARDS and cytokine storm associated with COVID-19.

机构信息

Faculty of Pharmacy, Medicinal Plants Research Center, Tehran University of Medical Sciences, Tehran, Iran.

Applied Biotechnology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.

出版信息

Mol Biol Rep. 2021 Dec;48(12):8221-8225. doi: 10.1007/s11033-021-06827-7. Epub 2021 Oct 15.

DOI:10.1007/s11033-021-06827-7
PMID:34655016
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8519322/
Abstract

Arglabin (l(R),10(S)-epoxy-5(S),5(S),7(S)-guaia-3(4),ll(13)-dien-6,12-olide), is a natural sesquiterpene γ-lactone which was first isolated from Artemisia glabella. The compound has been shown to possess anti-inflammatory activity through inhibition of the NLR Family pyrin domain-containing 3 (NLRP3) inflammasome and production of proinflammatory cytokines including interleukin (IL)-1β and IL-18. A more hydrophilic derivative of the compound also exhibited antitumor activity in the breast, colon, ovarian, and lung cancer. Some other synthetic derivatives of the compound have also been synthesized with antitumor, cytotoxic, antibacterial, and antifungal activities. Since both NLRP3 inflammasome and cytokine storm are associated with the pathogenesis of COVID-19 and its lethality, compounds like arglabin might have therapeutic potential to attenuate the inflammasome-induced acute respiratory distress syndrome and/or the cytokine storm associated with COVID-19.

摘要

阿格雷巴宾(l(R),10(S)-环氧-5(S),5(S),7(S)-愈创木-3(4),11(13)-二烯-6,12-内酯),是一种天然倍半萜 γ-内酯,最初从青蒿中分离得到。该化合物已被证明具有抗炎活性,可通过抑制NLR 家族吡喃结构域包含蛋白 3(NLRP3)炎症小体和产生包括白细胞介素(IL)-1β和 IL-18 在内的促炎细胞因子。该化合物的一种更亲水的衍生物也在乳腺癌、结肠癌、卵巢癌和肺癌中表现出抗肿瘤活性。该化合物的一些其他合成衍生物也具有抗肿瘤、细胞毒性、抗菌和抗真菌活性。由于 NLRP3 炎症小体和细胞因子风暴都与 COVID-19 的发病机制及其致死率有关,因此像阿格雷巴宾这样的化合物可能具有治疗潜力,可减轻炎症小体诱导的急性呼吸窘迫综合征和/或与 COVID-19 相关的细胞因子风暴。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cbf/8519322/f7f4cc644740/11033_2021_6827_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cbf/8519322/f7f4cc644740/11033_2021_6827_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cbf/8519322/f7f4cc644740/11033_2021_6827_Fig1_HTML.jpg

相似文献

1
Arglabin could target inflammasome-induced ARDS and cytokine storm associated with COVID-19.ArgL 可能靶向 COVID-19 相关的炎症小体诱导的 ARDS 和细胞因子风暴。
Mol Biol Rep. 2021 Dec;48(12):8221-8225. doi: 10.1007/s11033-021-06827-7. Epub 2021 Oct 15.
2
Targeting the NLRP3 Inflammasome in Severe COVID-19.针对严重 COVID-19 的 NLRP3 炎性小体。
Front Immunol. 2020 Jun 23;11:1518. doi: 10.3389/fimmu.2020.01518. eCollection 2020.
3
The NLRP3 inflammasome and COVID-19: Activation, pathogenesis and therapeutic strategies.NLRP3 炎性小体与 COVID-19:激活、发病机制和治疗策略。
Cytokine Growth Factor Rev. 2021 Oct;61:2-15. doi: 10.1016/j.cytogfr.2021.06.002. Epub 2021 Jun 18.
4
Targeting autophagy regulation in NLRP3 inflammasome-mediated lung inflammation in COVID-19.针对 COVID-19 中 NLRP3 炎性体介导的肺炎症中的自噬调控。
Clin Immunol. 2022 Nov;244:109093. doi: 10.1016/j.clim.2022.109093. Epub 2022 Aug 6.
5
Spontaneous NLRP3 inflammasome-driven IL-1-β secretion is induced in severe COVID-19 patients and responds to anakinra treatment.在重症 COVID-19 患者中可诱导自发 NLRP3 炎性小体驱动的 IL-1-β 分泌,并对阿那白滞素治疗有反应。
J Allergy Clin Immunol. 2022 Oct;150(4):796-805. doi: 10.1016/j.jaci.2022.05.029. Epub 2022 Jul 11.
6
Chloroquine/hydroxychloroquine: an inflammasome inhibitor in severe COVID-19?氯喹/羟氯喹:严重 COVID-19 中的一种炎症小体抑制剂?
Naunyn Schmiedebergs Arch Pharmacol. 2021 May;394(5):997-1001. doi: 10.1007/s00210-020-02034-6. Epub 2021 Jan 8.
7
Putative Therapeutic Impact of Inflammasome Inhibitors against COVID-19-Induced ARDS.针对 COVID-19 引发的 ARDS 的炎症小体抑制剂的潜在治疗影响。
Curr Med Chem. 2023;30(12):1406-1419. doi: 10.2174/0929867329666220906111550.
8
AntagomiRs: A novel therapeutic strategy for challenging COVID-19 cytokine storm.抗 miRNA:治疗 COVID-19 细胞因子风暴的新策略。
Cytokine Growth Factor Rev. 2021 Apr;58:111-113. doi: 10.1016/j.cytogfr.2020.09.001. Epub 2020 Sep 9.
9
Cannabinoids Alleviate the LPS-Induced Cytokine Storm via Attenuating NLRP3 Inflammasome Signaling and TYK2-Mediated STAT3 Signaling Pathways In Vitro.大麻素通过抑制 NLRP3 炎性小体信号通路和 TYK2 介导的 STAT3 信号通路减轻 LPS 诱导的细胞因子风暴。
Cells. 2022 Apr 20;11(9):1391. doi: 10.3390/cells11091391.
10
MCL Plays an Anti-Inflammatory Role in -Induced Immune Response by Inhibiting NF-B and NLRP3 Inflammasome Activation.MCL通过抑制NF-κB和NLRP3炎性小体激活在诱导的免疫反应中发挥抗炎作用。
Mediators Inflamm. 2017;2017:2432904. doi: 10.1155/2017/2432904. Epub 2017 May 31.

引用本文的文献

1
Advances in acute respiratory distress syndrome: focusing on heterogeneity, pathophysiology, and therapeutic strategies.急性呼吸窘迫综合征的进展:聚焦于异质性、病理生理学和治疗策略。
Signal Transduct Target Ther. 2025 Mar 7;10(1):75. doi: 10.1038/s41392-025-02127-9.
2
Exploring Bioactive Phytomedicines for Advancing Pulmonary Infection Management: Insights and Future Prospects.探索用于推进肺部感染管理的生物活性植物药:见解与未来展望
Phytother Res. 2024 Dec;38(12):5840-5872. doi: 10.1002/ptr.8334. Epub 2024 Oct 9.
3
Immunomodulating Phytochemicals: An Insight Into Their Potential Use in Cytokine Storm Situations.

本文引用的文献

1
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): An Update.严重急性呼吸综合征冠状病毒2(SARS-CoV-2):最新情况
Cureus. 2020 Mar 26;12(3):e7423. doi: 10.7759/cureus.7423.
2
Sesquiterpene Lactones from Artemisia Genus: Biological Activities and Methods of Analysis.蒿属植物中的倍半萜内酯:生物活性及分析方法
J Anal Methods Chem. 2015;2015:247685. doi: 10.1155/2015/247685. Epub 2015 Oct 1.
3
[Anti-inflammatory effect of arglabin and 11,13-dihydro-13-dimethylaminoarglabin hydrochloride].[阿格拉宾及盐酸11,13-二氢-13-二甲氨基阿格拉宾的抗炎作用]
免疫调节植物化学物质:对其在细胞因子风暴情况下潜在用途的洞察。
Adv Pharm Bull. 2024 Mar;14(1):105-119. doi: 10.34172/apb.2024.001. Epub 2023 Jul 19.
4
Isocorydine Ameliorates IL-6 Expression in Bone Marrow-Derived Macrophages and Acute Lung Injury Induced by Lipopolysaccharide.异紫堇定碱可减轻脂多糖诱导的骨髓来源巨噬细胞中白细胞介素 6 的表达和急性肺损伤。
Int J Mol Sci. 2023 Feb 27;24(5):4629. doi: 10.3390/ijms24054629.
5
Uncovering the information immunology journals transmitted for COVID-19: A bibliometric and visualization analysis.揭示 COVID-19 信息免疫学期刊传递的信息:文献计量学和可视化分析。
Front Immunol. 2022 Oct 31;13:1035151. doi: 10.3389/fimmu.2022.1035151. eCollection 2022.
6
The Role of Inflammasome NLPR3 in the Development and Therapy of Periodontitis.NLRP3 炎性小体在牙周炎发病机制和治疗中的作用。
Int J Med Sci. 2022 Sep 21;19(10):1603-1614. doi: 10.7150/ijms.74575. eCollection 2022.
7
NLRP-3 Inflammasome: A Key Target, but Mostly Overlooked following SARS-CoV-2 Infection.NLRP-3炎性小体:一个关键靶点,但在新型冠状病毒感染后大多被忽视。
Vaccines (Basel). 2022 Aug 12;10(8):1307. doi: 10.3390/vaccines10081307.
8
The NLRP3 Inflammasome Pathway: A Review of Mechanisms and Inhibitors for the Treatment of Inflammatory Diseases.NLRP3炎性小体通路:炎症性疾病治疗的机制与抑制剂综述
Front Aging Neurosci. 2022 Jun 10;14:879021. doi: 10.3389/fnagi.2022.879021. eCollection 2022.
9
COVID-19-induced immune thrombocytopenic purpura; Immunopathogenesis and clinical implications.新型冠状病毒肺炎(COVID-19)相关免疫性血小板减少性紫癜:免疫发病机制及临床意义
Infez Med. 2022 Mar 1;30(1):41-50. doi: 10.53854/liim-3001-5. eCollection 2022.
10
Anti-Inflammatory and Immunoregulatory Action of Sesquiterpene Lactones.倍半萜内酯的抗炎和免疫调节作用。
Molecules. 2022 Feb 8;27(3):1142. doi: 10.3390/molecules27031142.
Eksp Klin Farmakol. 2004 Jan-Feb;67(1):37-9.
4
Arglabin-DMA, a plant derived sesquiterpene, inhibits farnesyltransferase.阿格拉宾 - DMA,一种源自植物的倍半萜烯,可抑制法尼基转移酶。
Oncol Rep. 2001 Jan-Feb;8(1):173-9. doi: 10.3892/or.8.1.173.
5
In vitro biological activities of arglabin, a sesquiterpene lactone from the Chinese herb Artemisia myriantha Wall. (Asteraceae).来自中国草药多花蒿(菊科)的倍半萜内酯阿尔加宾的体外生物活性。
Biotechnol Ther. 1993;4(1-2):77-98.